+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific Tuberculosis Diagnosis and Treatment Market 2019-2025

  • PDF Icon


  • February 2020
  • Region: Asia Pacific
  • Orion Market Research Private Limited
  • ID: 5116837
UP TO OFF until Dec 31st 2022
Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Drugs Type (First Line Drugs and Second Line Drugs) By Diagnosis (Laboratory Testing, Nucleic Acid Amplification Test, Mantoux Test, Radiography and Drug Susceptibility Testing) Forecast period (2019-2025).

Asia-Pacific tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 2.8% during the forecast period. Largest number of new TB cases was reported in Asia accounting for 45% of new cases. Tuberculosis incidence, and mortality rate was comparatively higher in countries with lower human development index, gross domestic product (GDP) per capita, corruption perception index and countries with more people under minimum food supplements. Among the health system variables, governmental health expenditure per capita, total health expenditure per capita, access to improved water, hospital beds and sanitation are strongly associated with tuberculosis. As Asia is the region with most of the developing countries, unavailability of these system variables increases the incidences of tuberculosis in the Asia-pacific.

USAID has supported TB control and prevention in the Asia-Pacific region. Its major goal is the development as well as implementation of innovative and scalable programs for TB control in the Asia-Pacific region. The organization has been focusing on building comprehensive models to improve diagnosis, MDR-TB prevention, and treatment initiation, along with treatment success. USAID support strengthens national TB programs by assisting them and introducing innovative and cost-effective approaches to TB control. USAID along with countries government initiatives has been the major factor in the market growth.

Asia-Pacific tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.

The key players that are active in the market include Abbott Laboratories, Becton, Dickinson and Co., Biochemical and Synthetic Products Pvt Ltd, Eiken Chemical Co., Ltd., F. Hoffmann-La Roche Ltd., Labatec Pharma SA, Lupin Pharmaceuticals, Inc., Thermo Fisher Scientific and GlaxoSmithKline PLC.

Research Methodology:

The market study of the Asia-Pacific Tuberculosis Diagnosis and Treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Research and Analysis by Drugs Type
2. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Research and Analysis by Diagnosis

The Report Covers:
  • Comprehensive Research Methodology of the Asia-Pacific Tuberculosis Diagnosis and Treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific Tuberculosis Diagnosis and Treatment market.
  • Insights about market determinants which are stimulating the Asia-Pacific Tuberculosis Diagnosis and Treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • Biochemical and Synthetic Products Pvt Ltd.
  • Eiken Chemical Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Labatec Pharma SA
  • Lupin Pharmaceuticals, Inc.
  • Thermo Fisher Scientific